Case Reports in Immunology

Scope & Guideline

Innovating Treatment Approaches Through Detailed Case Analysis

Introduction

Welcome to your portal for understanding Case Reports in Immunology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2090-6609
PublisherHINDAWI LTD
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2016 to 2017, from 2019 to 2024
AbbreviationCASE REP IMMUNOL / Case Rep. Immunol.
Frequency-
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON W1T 5HF, ENGLAND

Aims and Scopes

The journal 'Case Reports in Immunology' aims to provide a platform for the dissemination of unique and clinically significant case reports related to immunological disorders. It emphasizes the importance of individual patient cases in understanding complex immunological phenomena, treatment responses, and disease mechanisms.
  1. Clinical Case Reports:
    The journal primarily publishes detailed clinical case reports that highlight unique aspects of immunological diseases, showcasing novel presentations and rare conditions.
  2. Treatment Responses and Efficacy:
    A focus on documenting treatment responses to various immunological therapies, including novel drug interactions and immunotherapy outcomes, is central to the journal's content.
  3. Genetic and Molecular Insights:
    Many papers explore genetic mutations and their implications in immunodeficiency and autoimmune diseases, providing critical insights into the molecular underpinnings of these conditions.
  4. Interdisciplinary Approaches:
    The journal encourages interdisciplinary research that combines immunology with other medical fields, such as rheumatology, dermatology, and oncology, showcasing the holistic nature of patient care.
  5. Literature Reviews:
    In addition to case reports, the journal frequently includes literature reviews that contextualize individual cases within the broader spectrum of existing research, enhancing the educational value for readers.
The journal has shown a dynamic evolution in its focus, with several emerging themes gaining traction in recent publications. These trends reflect current challenges and advancements in the field of immunology.
  1. COVID-19 Related Immunological Cases:
    There is a noticeable increase in case reports related to the immunological effects and complications of COVID-19, indicating a timely response to the global pandemic and its impact on immune health.
  2. Genetic Basis of Immunological Disorders:
    A rising trend in exploring genetic mutations associated with immunological disorders highlights the growing importance of genomics in understanding disease mechanisms and guiding treatment.
  3. Immunotherapy Outcomes:
    Case reports detailing the effects and complications of novel immunotherapies, including immune checkpoint inhibitors, are increasingly prevalent, reflecting the rapid advancements in cancer immunotherapy.
  4. Complex Interactions of Autoimmunity and Infectious Disease:
    There is a growing focus on cases that illustrate the interplay between autoimmune conditions and infectious diseases, emphasizing the need for comprehensive management strategies in affected patients.
  5. Multisystem Involvement in Immunological Disorders:
    Emerging cases demonstrate multisystem involvement in immunological diseases, indicating a trend toward understanding the broader implications of these disorders beyond isolated symptoms.

Declining or Waning

While 'Case Reports in Immunology' has consistently focused on various immunological cases, certain themes have shown signs of decline in frequency or prominence over recent years. These waning scopes may reflect shifts in research trends or clinical practice.
  1. Traditional Immunodeficiency Disorders:
    Reports on well-established immunodeficiency disorders, such as Severe Combined Immunodeficiency (SCID), have become less frequent, possibly due to advancements in genetic screening and early diagnosis reducing the number of novel cases.
  2. Classic Autoimmune Diseases:
    Cases focusing on classic autoimmune diseases like rheumatoid arthritis or lupus are appearing less often, as the journal increasingly highlights more niche or complex immunological conditions.
  3. Simple Drug Reactions:
    While drug reactions are still relevant, the journal has moved toward more complex cases involving multiple variables, leading to a decrease in simpler drug reaction case reports.

Similar Journals

Case Reports in Hematology

Advancing understanding through innovative case reports.
Publisher: HINDAWI LTDISSN: 2090-6560Frequency: 1 issue/year

Case Reports in Hematology, published by HINDAWI LTD, stands as a prominent open-access journal dedicated to disseminating innovative case reports that contribute significantly to the field of hematology. Established in 2011, this journal provides a vital platform for researchers, practitioners, and clinicians to share detailed observations and novel findings related to blood disorders and treatment responses. With its commitment to high-quality research and accessibility, Case Reports in Hematology aims to enhance the understanding of hematological conditions, fostering collaboration and dialogue among professionals in the discipline. By leveraging an open-access model, the journal ensures that its valuable content is readily available to a global audience, consequently promoting advanced research and improving patient care in hematology. As a testament to its academic rigor and relevance, the journal appeals to its readership, which includes researchers, healthcare professionals, and students eager to expand their knowledge and insights into this critical area of medicine.

SAGE Open Medical Case Reports

Transforming Case Reports into Global Learning
Publisher: SAGE PUBLICATIONS INCISSN: 2050-313XFrequency: 1 issue/year

SAGE Open Medical Case Reports, published by SAGE Publications Inc, is a pioneering open-access journal dedicated to the rapid dissemination of medical case reports that significantly contribute to clinical knowledge and practice. Since its launch in 2013, this journal has become a valuable resource for healthcare professionals, researchers, and students in the field of medicine, facilitating the exchange of unique clinical experiences from around the globe. While the journal is categorized as Q4 in the Medicine (miscellaneous) quartile and holds a Scopus rank of 423 out of 636 in the General Medicine category, the accessibility of its content underscores its commitment to enhancing medical education and informing practice. With no subscription barriers, it supports the sharing of critical insights appropriate to a diverse audience, thereby fostering a culture of innovation and collaboration in healthcare.

American Journal of Case Reports

Empowering healthcare professionals with impactful case reports.
Publisher: INT SCIENTIFIC INFORMATION, INCISSN: Frequency: 1 issue/year

The American Journal of Case Reports, published by INT SCIENTIFIC INFORMATION, INC since 2008, serves as a crucial platform in the field of Medicine, specifically focusing on clinical cases that enhance medical knowledge and expertise. With an impact factor that reflects its quality and relevance, this journal ranks in the Q3 quartile of its category and holds a notable position at Rank #259 out of 636 in the Scopus Medicine rankings, placing it within the 59th percentile among its peers. Intended for researchers, healthcare professionals, and students, the American Journal of Case Reports advocates for the sharing of distinctive case studies, thus fostering a deeper understanding of clinical practice and patient care across a spectrum of medical disciplines. As an open access journal, it ensures widespread dissemination of vital case reports, opening avenues for global collaboration and knowledge exchange, ultimately enhancing evidence-based practice in medicine.

AUTOIMMUNITY REVIEWS

Illuminating the path in autoimmune disease understanding.
Publisher: ELSEVIERISSN: 1568-9972Frequency: 8 issues/year

AUTOIMMUNITY REVIEWS is an esteemed journal in the field of immunology and allergy, published by Elsevier and located in the Netherlands. With a remarkable impact reflected in its Q1 category rankings for both Immunology and Allergy, this journal stands at the forefront of advancing research and knowledge in autoimmune diseases. Its Scopus rankings are particularly notable, placing it at #14 in the Immunology and Allergy category and #17 in the broader scope of Immunology and Microbiology, underscoring its influential role in the scientific community with a commendable 94th percentiles in both domains. Since its inception in 2002, AUTOIMMUNITY REVIEWS has provided a multidisciplinary platform for researchers and practitioners to share landmark studies, case reports, and reviews that propel the understanding of autoimmune disorders. Although it does not currently operate under an open-access model, the journal ensures rigorous peer review and high-quality publications, making it an essential resource for anyone looking to stay informed about the latest developments in autoimmune research.

Leukemia Research Reports

Empowering breakthroughs in hematology and oncology.
Publisher: ELSEVIER ADVANCED TECHNOLOGYISSN: 2213-0489Frequency: 2 issues/year

Leukemia Research Reports, published by Elsevier Advanced Technology, is a prominent open-access journal dedicated to the latest advancements in the field of hematology and oncology. Since its launch in 2012, this journal has been a vital resource for researchers, healthcare professionals, and students aiming to disseminate and access high-quality research articles focused on various aspects of leukemia and related blood disorders. With an impact factor indicative of its significance in the field, Leukemia Research Reports currently holds a Q3 quartile ranking in both Hematology and Oncology, and is included in key databases such as Scopus. The journal not only embraces a commitment to open access, ensuring that research is freely available, but also actively promotes collaborations that strive to enhance our understanding and treatment of leukemia. Based in the United Kingdom, this journal continues to play a crucial role in fostering innovation and knowledge sharing within the medical community.

Case Reports in Infectious Diseases

Highlighting innovative treatments for global impact.
Publisher: HINDAWI LTDISSN: 2090-6625Frequency: 1 issue/year

Case Reports in Infectious Diseases is a premier open-access journal published by Hindawi Ltd, dedicated to advancing the field of infectious disease research through the dissemination of case reports that highlight unique clinical presentations, innovative treatment approaches, and novel diagnostic techniques. Since its inception in 2011, this journal has provided a vital platform for healthcare professionals, academicians, and researchers to share their findings, thereby enhancing the collective understanding of infectious diseases. Featuring a diverse range of case studies, the journal aims to inspire further research and clinical inquiry, making it an invaluable resource for anyone involved in the fight against infectious diseases. With an easily accessible online format, it caters to a global audience, ensuring that critical insights are available to all stakeholders in this crucial field.

AIMS Allergy and Immunology

Exploring Breakthroughs in Allergy Research
Publisher: AMER INST MATHEMATICAL SCIENCES-AIMSISSN: 2575-615XFrequency: 4 issues/year

AIMS Allergy and Immunology is a prestigious open access journal dedicated to advancing knowledge in the fields of allergy and immunology. Published by the American Institute of Mathematical Sciences (AIMS), this journal provides a vibrant platform for researchers, practitioners, and scholars to share groundbreaking findings and insights. Recognized for its commitment to disseminating high-quality research since its inception in 2017, AIMS Allergy and Immunology contributes significantly to the understanding of complex immunological mechanisms and allergic responses, thus playing a pivotal role in enhancing clinical practices and therapeutic strategies. With its ISSN 2575-615X, the journal aims to facilitate a robust exchange of ideas and promote collaboration within the scientific community. Researchers and practitioners are encouraged to access the latest studies and reviews, which are all freely available online, ensuring that vital information reaches a global audience without barriers. Together, we can tackle the challenges posed by allergies and immune disorders through rigorous scientific inquiry and innovation.

CLINICAL NEUROPATHOLOGY

Empowering clinical practice through innovative neuropathology research.
Publisher: DUSTRI-VERLAG DR KARL FEISTLEISSN: 0722-5091Frequency: 6 issues/year

CLINICAL NEUROPATHOLOGY is a vital scholarly journal published by DUSTRI-VERLAG DR KARL FEISTLE, specializing in the domains of neurology, pathology, and their clinical applications. Established in 1982 and spanning through to its projected completion in 2024, this journal disseminates high-quality research that significantly contributes to the understanding of neurological disorders and their pathological underpinnings. While the journal currently operates under a traditional access model, its commitment to rigorous peer review ensures the publication of impactful findings, strengthening its foothold in the field, as evidenced by its Q3 quartile rankings in several categories, including Medicine (miscellaneous), Neurology, and Pathology and Forensic Medicine. Those engaged in clinical research and practice will find CLINICAL NEUROPATHOLOGY to be an essential resource for the latest advancements, trends, and discussions that shape the future of neurological pathology.

Journal of Cutaneous Immunology and Allergy

Advancing knowledge at the intersection of skin, immunity, and allergy.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 6 issues/year

The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.

Case Reports in Dermatology

Pioneering the future of dermatology with every case report.
Publisher: KARGERISSN: 1662-6567Frequency: 3 issues/year

Case Reports in Dermatology is a leading Open Access academic journal dedicated to the publication of case reports and unique clinical findings in the field of dermatology. Published by KARGER and based in Switzerland, the journal has been an open access resource since 2009, enhancing the visibility and accessibility of vital research for dermatology professionals and the scientific community. With an impressive ISSN of 1662-6567 and ranking in the Q3 category among dermatological journals, it serves as a crucial platform for researchers seeking to share innovative case studies, validate diagnostic approaches, and explore treatment outcomes. The journal continues to contribute to advancing dermatological science with a convergence timeline extending from 2010 to 2024. By promoting the dissemination of emerging knowledge and practices, Case Reports in Dermatology plays a significant role in fostering collaboration among practitioners, enhancing educational efforts, and ultimately improving patient care in dermatology.